Edition:
United States

Health News

Photo

Novartis says 82 percent of leukemia patients in remission after CAR-T Dec 03 2016

An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form of blood cancer in 82 percent of children and young adults treated with modified immune cells in a mid-stage trial, the company said on Saturday.

More Headlines

Higher blood clot risk after starting testosterone treatment

(Reuters Health) - - Men may have an increased risk of blood clots after they start taking testosterone to treat sexual dysfunction, a recent study suggests.

Dec 02 2016
Photo

Heavy teenage drinking linked to abnormal brain development

(Reuters Health) – - Teens who drink heavily are more likely than their peers to have less gray matter, an important brain structure that aids in memory, decisions, and self-control, according to a Finnish study.

Dec 04 2016
Photo

FDA lets Lilly cite Jardiance heart data, shares jump

U.S regulators said on Friday they would allow Eli Lilly and Co to state that its diabetes drug Jardiance reduces risk of death from heart problems, lifting company shares almost 3 percent and potentially giving a strong boost to the drug's future sales.

Dec 04 2016
Photo

U.S. health spending in 2015 rose at fastest rate since 2007

U.S. health spending in 2015 rose at its fastest rate since 2007, driven by expanded access to insurance under the Affordable Care Act and high-priced specialty drugs, according to government figures released on Friday.

U.S., Drug Pricing Dec 04 2016

Health Watch Graphics